Absci reports full year 2021 financial and operating results

Vancouver, wash., march 22, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter and full year ended december 31, 2021.
ABSI Ratings Summary
ABSI Quant Ranking